A right of first refusal, or ROFR, is a common clause in contracts. It’s also remarkably powerful: by giving one party exclusive access to a transaction before anybody else, an owner limits not just the actions of interested third parties, but also of themselves.
In this video, Torys litigators Andrew Bernstein, Jeremy Opolsky and Rachael Saab explain how businesses can deploy this powerful tool with appropriate care in their commercial contracts.
We discuss:
Click here to see other videos in this series.
Andrew Bernstein (00:07): Hi everyone, and welcome to Torys' Commercial Disputes video series. I'm Andrew Bernstein, the host and moderator of this series. I'm delighted to have two of my colleagues from Torys' litigation department, Jeremy Opolsky and Rachael Saab. And today we're going to talk about rights of first refusal. So Jeremy, let's start with you. What is a right of first refusal in common law?
Jeremy Opolsky (00:28): A right of first refusal, or as I call it, and we might call it during this seminar, a "ROFR" are contractual rights to enter into a transaction before someone else can, effectively. Or anyone else. You often see them in real estate transactions, including in leases, but you can see them in any context, shares or other assets that parties are interacting with respect to the ownership of.And generally, a ROFR has three parties. They have the property owner, they have the third-party purchaser—a purported purchaser—and they have an option holder. And the ROFR is triggered when the owner wants to sell the property. It has an offer to sell it to a third party. And it has to go to the option holder and say effectively, "Do you want to buy this property on the same terms?"
Andrew Bernstein (01:14): Rachael, how is a right of first refusal or a ROFR, as Jeremy likes to call it, different from a right of first offer or a "ROFO"?
Rachael Saab (01:23): So the ROFO is different from the ROFR in that it only obliges the owner to engage in exclusive, good faith negotiations with the rights holder before negotiating with other parties. So it's a first offer, not a first refusal. This is a place where it's really important to clearly delineate the scope of negotiation contemplated by the ROFO in the contract. So what is required of each party?How long are negotiations going to be open for? You want to make sure that all of those things are clear in the contract. And similarly, it's also important to keep the scope of a ROFR in mind. For example, is the ROFR only over specific assets and if it's only over specific assets, does that extend to a change of control?And that's likely not the case unless it's specifically indicated in the ROFR, but it's important when you're thinking about a ROFR to ask those questions when you're drafting and considering your rights.
Andrew Bernstein (02:26): Yes, and another place that I see this sometimes is in the context of inter corporate transactions, where you don't really want to transfer the asset out of the company, but you want to transfer the asset from one corporate entity to another. Does it trigger the ROFR? When does it trigger the ROFR? Okay. So we've talked a little bit about drafting the ROFR, but talk about what happens when you come up against a ROFR.
Rachael Saab (02:48): Yeah. So lots of people give ROFRs, but it's something to be really cautious about. And you might think, well, this is no big deal because they can't stop me from selling ultimately. But the reality is that ROFRs can make everything a lot more complicated in a sale process. First, it can be hard to get a third party to negotiate for an asset that's subject to a ROFR.And that's obvious why that would be the case. Why would a third party put in all the time and effort to do that when someone can just swoop in and take the deal away from you? And second, once you have a third party agree on terms, everyone just wants to sign the deal. But there's usually a notice period where everyone has to wait until the ROFR holder decides whether they want to adopt the third party's terms or reject them.And you can bet there will be fights about what are the material terms and how much flexibility the ROFR holder has to amend the agreements. And lastly, if you're the third party who is up against a ROFR, you have to think about these things and ask yourself questions like, do I want to start here? How long am I willing to remain in limbo?And what might I be revealing about my business strategy when the ROFR holder sees the agreement as they ultimately will?
Andrew Bernstein (04:07): Thank you, Rachael. Jeremy, let's change the subject a little bit and ask this question, which is, are there circumstances in which being the owner of a ROFR can hurt you? It seems like ROFR, by its nature, is an option. So what would the problem be if you are an option holder?
Jeremy Opolsky (04:26): Well, Andrew, I don't know if it can hurt you, but I think the theme that you'll hear today is that courts interpret ROFRs substantively and they give them a lot of weight both ways. If parties are going to agree to a ROFR courts have generally felt, that it has to mean something. And since the three of us are litigators, let's talk a little bit about litigation where this has come up.It's come up recently at the Ontario Court of Appeal in a case called Goodlife Fitness and Rock Developments Inc. And there, there were intersecting or overlapping contractual provisions, a ROFR and a non-compete. And the court was asked to find or was asked whether the non-compete could be exercised after a ROFR had already been raised and not taken advantage of.In that case, Goodlife had a ROFR over a property, also a non-compete both from the landlord that he would effectively, if he was going to lease for another gym, he would give Goodlife the first offer, the ROFR, right of first refusal. And there was also a non-compete to not lease it to a different gym or wellness venture.Goodlife was given the ROFR and they declined to exercise the ROFR when the lease came up and the developer went out and leased it to another gym. Later, Goodlife then said that lease was void because it violated the non-compete. The Court of Appeal disagreed and they said that the non-compete did not take precedence and could not take precedence over the ROFR and prevent the competitor from leasing that gym, where Goodlife chose not to exercise the ROFR. And ultimately the Court of Appeal foundwas that the contractual provisions, like all contractual provisions, have to be read together. And for the ROFR to have the substantive weight it needed, you couldn't allow non-compete to effectively come in and give Goodlife a second kick of the can. The plain language of the ROFR should prevail. If Goodlife decided not to exercise its right to lease the property, then the landlord was free to give it to the party that had triggered the ROFR in the first place.
Andrew Bernstein (06:31): Huh. Interesting. Okay, so Rachael, ROFRs sound pretty powerful. What else should we know about them?
Rachael Saab (06:38): That's true, Andrew. They are pretty powerful. And in fact, there is a tendency to interpret any discretionary aspects of a ROFR in favour of the ROFR holder. And we saw this in a different decision from the Court of Appeal for Ontario, which restricted the application of a specific ROFR limitation, which on its face would terminate the ROFR if either the landlord or the tenant gave notice to terminate the lease. And the Court of Appeal in that case held that the landlord couldn't just terminate the leases to avoid the ROFR,and in fact, the provision was read in a way that the tenant was actually entitled to be given a chance to exercise the ROFR before the landlord was entitled to terminate the lease.
Andrew Bernstein (07:23): Okay. Jeremy, the way that Rachael's describing the treatment of ROFRs makes me think about the duty of good faith, which I know there's another video about in this series. So does this ring some bells for you?
Jeremy Opolsky (07:36): I mean, that's right Andrew. And our audience for this video should absolutely have watched the other video as well. But it's true what Rachael was talking about. Discretion is a broader theme in recent Canadian jurisprudence, that there is a general duty of good faith in all contracts. And the duty of good faith requires parties that hold discretionary powers not to deal with them in a way that is arbitrary or capricious, deal with them in a way that is reasonable.In the ROFR context we've seen courts interpret what that reasonableness means, is to give life to the ROFR itself. To give the parties what they bargained for in a real ROFR and not allow parties to use technical discretionary choices under the ROFR provisions to defeat the purpose of the ROFR itself. A party is a real option to exercise that right of first refusal and needs to be given a real substantive right to do so.
Andrew Bernstein (08:30): I hear that the panelists in that other good faith video are not only extremely smart and very articulate, but also very attractive.
Jeremy Opolsky (08:38): I heard they were terrible.
Andrew Bernstein (08:39): Oh, okay.
Jeremy Opolsky (08:40): I heard they were terrible.
Andrew Bernstein (08:41): Rachael?
Rachael Saab (08:41): I hadn't heard that, Jeremy.
Andrew Bernstein (08:42): Okay.
Rachael Saab (08:43): I heard Andrew's rumour.
Andrew Bernstein (08:44): Yeah. I guess people will have to watch for themselves and see—
Rachael Saab (08:46): Decide for yourselves.
Andrew Bernstein (08:47): Rachael, what happens if a party breaches a ROFR?
Rachael Saab (08:53): So the general rule of remedies is that a party gets damages unless it can demonstrate that specific performance is appropriate. And that rule applies in this context as well. But you do need to consider, in the case of a ROFR, the damages may be difficult to calculate in these circumstances. It's really difficult to assess in monetary terms the damage that a party has suffered by virtue of the lost opportunity to exercise a ROFR.
Jeremy Opolsky (09:21): Rachael is entirely right and the risk here for the party that is breaching the ROFR, often the property owner, is that specific performance could be ordered by a court. Specific performance is difficult to get, but the types of property that ROFRs are granted on generally—real property, shares—are the kind of property that have that uniqueness that can give way to a remedy in specific performance.
Jeremy Opolsky (09:49): So you could find yourself saying, "Well, I'll just provide the damages if the party loses the ROFR" if you're going to breach it as a property owner, and you could find yourself instead being ordered to convey that property at great cost to you as a result of the breach.
Andrew Bernstein (10:04): Right. And presumably, there's some risk for a third-party buyer who's buying the product, or sorry, the asset when they know of the ROFR.
Jeremy Opolsky (10:14): But because we're litigators, I should add, it's case dependent. You should consult your lawyer.
Rachael Saab (10:19): It depends.
Andrew Bernstein (10:20): It depends. Okay well, that's insightful. Any takeaways other than "It depends" before we wrap up, Jeremy?I think Andrew, as I mentioned before, if you're going to grant a ROFR, you just need to expect that it's going to be given a lot of substantive weight by a court. Courts aren't going to give way to technical arguments generally about you complied technically, effectively, and didn't give the other side a real right or an option to buy the property.
Jeremy Opolsky (10:49): So if you're going to enter into a ROFR as a property owner, know what you're doing, you could be making a mess and problems for yourself later down the road.
Andrew Bernstein (11:00): Rachael, last word to you—well except for my charming outro. So last substantive word to you.
Rachael Saab (11:05): I think I'm going to leave you with a tip that, as always, clear drafting is key, especially in this context. You want to ensure that the agreement identifies the terms on which the ROFR or the ROFO can be exercised. So think about specifying how long the offer is open for, whether the rights holder should be entitled to exercise the ROFR for a specific price or on specific terms.Just think through the steps that you would need to take in the ROFR process and make sure that those are clearly set out in the contract. Because if you end up in a dispute about the ROFR, this is going to help the court determine its scope and not going to leave that to the thorny area of discretion.
Andrew Bernstein (11:50): Okay. Well, thank you, Rachael and Jeremy, for sharing your insight with us today. Watch for the next video in the series, which will be coming soon. I'm Andrew Bernstein from Torys and thanks for joining us.
Le mois dernier, le Canada a publié sa première Stratégie industrielle de défense (la Stratégie), qui souligne l’engagement du Canada à développer une base industrielle de défense solide et à stimuler la croissance économique. Ces efforts pourraient aussi comprendre le renforcement de l’état de préparation à la biodéfense et aux contre-mesures médicales, ce qui pourrait constituer des débouchés pour le secteur canadien des sciences de la vie en raison de l’importance accordée aux capacités nationales en ce sens et de la nécessité d’atténuer les risques d’urgences sanitaires.
Comme indiqué dans les bulletins précédents, le quatrième pilier de la Stratégie est axé sur la « sécurisation des chaînes d’approvisionnement pour les intrants et les biens clés » par le renforcement de la production nationale et le stockage de ressources. L’accent est mis tout particulièrement sur les contre-mesures médicales, en précisant que nos « alliés ont établi un lien explicite entre l’état de préparation à la biodéfense et aux contre-mesures médicales et leur sécurité économique et nationale, en élaborant de nouvelles stratégies et de nouveaux mécanismes pour faire progresser ces travaux ». Les contre-mesures médicales désignent divers produits réglementés pouvant être utilisés pour protéger la population lors d’une situation d’urgence de grande ampleur, comme l’éclosion d’une maladie ou une attaque impliquant des armes chimiques, biologiques ou nucléaires. Il peut s’agir de vaccins, de médicaments thérapeutiques et produits biologiques, de dispositifs de tests diagnostiques, des équipements de protection individuelle ou industrielle, et d’autres dispositifs médicaux. Les contre-mesures médicales sont essentielles à la réduction et à l’atténuation des dommages lors d’une urgence de santé publique.
Pendant et après la pandémie de COVID-19, le Canada a mis en place plusieurs nouvelles voies réglementaires comme mécanismes d’accélération des approbations de produits médicaux, ce qui pourrait offrir au gouvernement des options pour déployer des contre-mesures médicales afin de faire face aux risques pour la santé publique. Au début de la pandémie, Santé Canada a émis diverses ordonnances provisoires pour permettre l’importation et la vente de médicaments et de dispositifs médicaux qui n’avaient pas eu l’approbation des voies réglementaires traditionnelles. Or, Santé Canada a plutôt fait confiance aux voies d’approbation réglementaire et de l’exemption de certaines exigences en homologation de produits des pays impliqués dans la transaction. Beaucoup de ces règles provisoires ont depuis été officiellement intégrées à la réglementation en vertu de la Loi sur les aliments et drogues et ont été appliquées bien après la COVID-19. Conformément au Règlement sur les aliments et drogues, Santé Canada tient à jour la Liste des maladies qui menacent la santé publique et utilisera une procédure d’autorisation modifiée pour les médicaments d’urgence de santé publique pouvant traiter les affections figurant sur la liste. De même, le Règlement sur les instruments médicaux a établi une liste d’instruments médicaux répondant à un besoin urgent de santé publique, ce qui permet à Santé Canada d’autoriser la commercialisation de ces instruments de manière accélérée. Ces outils réglementaires sont utilisés automatiquement quand une situation médicale présente un grand risque pour la santé publique au Canada et nécessite une action immédiate pour contrer ce risque.
La stratégie prévoit que le Canada adoptera une approche proactive en matière de planification en amont des crises sanitaires. Le gouvernement entend s’assurer que les produits médicaux sont déjà disponibles au Canada afin qu’ils puissent être distribués rapidement en cas d’urgence. D’autres modifications récentes au Règlement sur les aliments et drogues permettent de prépositionner au Canada tous les médicaments d’urgence en santé publique, ce qui signifie qu’ils peuvent être importés dans des installations d’entreposage canadiennes avant que leur mise sur le marché n’ait été autorisée. La Stratégie s’appuie sur ces fondements, en faisant référence à l’organisme existant Préparation aux crises sanitaires Canada (PCSC), un organisme opérationnel spécial au sein d’Innovation, Sciences et Développement économique Canada (ISDE), et à un nouveau Fonds des sciences de la vie, lesquels « collaborent avec des partenaires internationaux et de soutenir l’élaboration et la production de contre-mesures médicales ». PCSC supervise la Stratégie en matière de biofabrication et de sciences de la vie du Canada, qui vise à développer un secteur national des sciences de la vie fort et compétitif doté de capacités de biofabrication de pointe, en mettant l’accent sur la capacité à se préparer et à faire face aux futures priorités et crises sanitaires. Dans cette optique, il y aura des occasions pour les fabricants de nouer des collaborations de recherche et des accords commerciaux ou d’approvisionnement liés aux contre-mesures médicales financées par des programmes fédéraux.
Étroitement lié aux capacités nationales, le pilier III de la stratégie implique « Investissement ciblé pour renforcer un secteur canadien de la défense novateur », avec la promesse que le gouvernement fédéral « soutiendr[a] la recherche et le développement, protéger[a] la propriété intellectuelle, soutiendr[a] les petites et moyennes entreprises, investir[a] dans les compétences et la formation, et encourager[a] les exportations afin de créer un secteur de la défense agile et concurrentiel à l’échelle mondiale ». La nécessité de favoriser le développement de la propriété intellectuelle (PI) et la conservation des droits du Canada est mentionnée à plusieurs reprises dans la Stratégie. Par exemple, la Stratégie prévoit l’établissement de partenariats officiels avec l’industrie canadienne qui « [assureront] la propriété et le contrôle nationaux de la propriété intellectuelle (PI) et des capacités essentielles. » La Stratégie reconnaît l’immense talent des établissements canadiens et la précieuse recherche qui y est menée actuellement et qui est déjà financée par des subventions de recherche d’organismes tels que le Conseil de recherches en sciences naturelles et en génie et les Instituts de recherche en santé du Canada, et fait aussi référence à l’engagement de 1,6 milliard de dollars pour de nouveaux fonds de recherche dans le budget de 2025. Cette prise de conscience de la nécessité de promouvoir et de soutenir l’innovation au Canada laisse présager des possibilités de financement, notamment dans les domaines où le Canada accuse un retard en matière de production nationale et où des engagements d’investissement et de fabrication au Canada peuvent être pris.
Dans les prochains mois, nous prévoyons que le gouvernement du Canada publiera d’autres directives et des mesures de suivi. L’équipe de défense des conservateurs poursuivra sa couverture de perspectives sur la défense au Canada en publiant une analyse supplémentaire pour donner des précisions sur l’incidence de la Stratégie sur de multiples secteurs.